ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,485Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 487

$679K Total Retail Price of All Prescriptions

Rank: 13 out of 487

483 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 483 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,856 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 563 357 1 1
OMEPRAZOLE 407 243 2 2
HYDROCODONE-ACETAMINOPHEN 322 257 S3 3 3
SIMVASTATIN 310 219 4 4
WARFARIN SODIUM 278 232 5 11
FUROSEMIDE 258 180 6 7
CITALOPRAM HBR 237 186 7 12
LISINOPRIL 226 192 8 5
ZOLPIDEM TARTRATE 200 132 9 14
DONEPEZIL HCL 195 177 10 38
GABAPENTIN 193 175 11 13
FLUOXETINE HCL 178 84 12 28
METFORMIN HCL 174 97 13 8
AMLODIPINE BESYLATE 172 160 14 6
METOPROLOL SUCCINATE 170 116 15 15
HYDROCHLOROTHIAZIDE 168 132 16 9
POTASSIUM CHLORIDE 163 111 17 10
PAROXETINE HCL 155 64 18 51
TRAMADOL HCL 148 91 19 19
FENTANYL 146 126 S2 20 36
RANITIDINE HCL 134 95 21 39
RISPERIDONE 133 96 22 58
CYMBALTA 128 70 23 34
ALENDRONATE SODIUM 108 74 24 27
NAMENDA 106 96 25 53
LANTUS 102 102 26 44
CARBAMAZEPINE 100 12 27 136
LOSARTAN POTASSIUM 96 87 28 16
TAMSULOSIN HCL 94 62 29 25
ESTRADIOL 90 58 R 30 68
MELOXICAM 90 64 30 26
DIVALPROEX SODIUM 85 24 32 86
SULFAMETHOXAZOLE-TRIMETHOPRIM 80 43 33 90
CARVEDILOL 80 75 33 32
CELEBREX 80 48 33 103
METOPROLOL TARTRATE 79 67 36 17
NAPROXEN 78 50 37 109
VENLAFAXINE HCL ER 77 18 38 55
AMITRIPTYLINE HCL 76 41 R 39 45
FLUTICASONE PROPIONATE 76 42 39 33
NEXIUM 76 33 39 41
ALLOPURINOL 70 58 42 29
ATORVASTATIN CALCIUM 70 53 42 18
BENZTROPINE MESYLATE 69 24 R 44 117
METFORMIN HCL ER 65 47 45 31
PREDNISONE 63 49 46 37
FAMOTIDINE 61 37 47 94
LAMOTRIGINE 60 0 48 106
ROPINIROLE HCL 59 37 49 60
POLYETHYLENE GLYCOL 3350 58 36 50 56
AMLODIPINE BESYLATE-BENAZEPRIL 56 46 51 92
CLONIDINE HCL 56 43 51 82
BACLOFEN 55 0 53 71
SPIRIVA 55 45 53 48
NABUMETONE 53 14 55 148
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.